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ARTICLE SUMMARY
Serum CA-125 is commonly used as a marker for ovarian cancer (1,2), although it can be elevated in nongynecological malignancy and benign gynecological disease (2) . In this prospective study, serum CA-125 was measured pre-and postliver transplantation in 57 cirrhotic patients (67% men) as well as two patients with polycystic liver disease and abdominal distention without ascites. Ascitic CA-125 levels were determined in five patients who had paracentesis. Mesothelial CA-125 staining was performed in 16 hepatectomy specimens. The mean serum CA-125 level pretransplant was 352±549 U/L (normal less than 37 U/L) and 46±49 U/L post-transplant (P<0.001). The mean ascitic CA-125 was 951±322 U/L compared with the mean serum level of 619±290 U/L (P<0.003). The CA-125 mesothelial staining grade was 0.8±1.4 and 1.5±1.1 in patients with normal and elevated serum CA-125 (P=0.37). The two patients with polycystic liver disease without ascites also had elevated CA-125. On multivariate analysis, ascites was the only predictive variable for elevated serum CA-125.
COMMENTARY
Despite its lack of specificity, the CA-125 is commonly used in clinical practice as a serological screen and for follow-up of ovarian cancer. Ordinarily, hepatologists do not follow the CA-125 unless an ultrasound report happens to describe an ovarian mass. The situation is different for patients undergoing work-up for liver transplantation, because many centres include a battery of tumour markers as part of the screening process. A grossly elevated serum CA-125 in these circumstances often produces concern that an ovarian cancer, which would be a contraindication for transplantation if not curatively treated, is present. The study of the McGill University group adds to the body of evidence that the serum CA-125 can be elevated in cirrhosis in the absence of ovarian cancer. This study also strongly suggests that it is, in fact, the presence of increased intra-abdominal pressure, which results in a reactive mesothelial cell mediated increase in serum CA-125. Recently there have been other reports of an elevated serum CA-125 in the presence of cirrhosis and ascites, and some have even suggested that the serum CA-125 be used as a marker for the presence of ascites (3)! Furthermore, it has also become clear that noncirrhotic ascites (4) and peritoneal tuberculosis (5) can produce elevated serum CA-125 levels. For the transplant hepatologists confronted with an elevated serum CA-125 in a pretransplant patient, the bottom line is -if the pelvic ultrasound is normal, rest easy.
